BioPlus Acquisition Long Term Debt

BioPlus Acquisition (BIOS) currently reports a long-term debt of $5M as of June 2023. That compares with $5M in the prior-year period — up 0.0% year over year. Use the charts on this page to explore BioPlus Acquisition's long-term debt history and peer comparisons.

BioPlus Acquisition's long-term debt was unchanged from $5M to $5M — essentially flat versus a year earlier (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioPlus Acquisition reported $5M in long-term debt as of June 2023. That compares with $5M in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioPlus Acquisition, and consider following BIOS for alerts when major investors trade the stock.